Charlotte's Web Holdings Inc Share Price Canadian Securities Exchange

Equities

CWEB

CA16106R1091

Pharmaceuticals

Delayed Canadian Securities Exchange 5-day change 1st Jan Change
- CAD -.--% Intraday chart for Charlotte's Web Holdings Inc -1.63% +27.22%

Financials

Sales 2024 * 64.73M 88.79M 5.4B Sales 2025 * 65.14M 89.35M 5.43B Capitalization 29.14M 39.96M 2.43B
Net income 2024 * -33M -45.26M -2.75B Net income 2025 * - EV / Sales 2024 * 0.45 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * 0.45 x
P/E ratio 2024 *
-0.84 x
P/E ratio 2025 *
-
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 88.69%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Charlotte's Web Holdings Inc

Managers TitleAgeSince
Chief Executive Officer 60 13/23/13
Founder 37 03/13/03
Director of Finance/CFO 36 01/23/01
Members of the board TitleAgeSince
Chairman 61 18/18/18
Director/Board Member 52 06/22/06
Director/Board Member 63 10/22/10
More insiders
Charlotte's Web Holdings, Inc. (Charlotte’s) is engaged in providing hemp extract wellness products under a family of brands which includes Charlotte’s Web, CBD Medic, CBD Clinic, and Harmony Hemp. Charlotte’s Web branded products start with its hemp genetics that are 100% North American farm grown and manufactured into hemp extracts containing naturally occurring phytocannabinoids, including cannabidiol (CBD), cannabichromene (CBC), cannabigerol (CBG), cannabinol (CBN), terpenes, flavonoids and other beneficial hemp compounds. Charlotte’s Web product categories include full spectrum hemp extract oil tinctures (liquid products), gummies (sleep, calm, immunity, exercise recovery, daily wellness, THC-free), capsules, topical creams and lotions, as well as CBD pet products for dogs. Charlotte’s Web products are distributed to retail outlets and health care practitioners, as well as online through the Company’s Website at www.Charlottesweb.com.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
0.1853 USD
Average target price
0.554 USD
Spread / Average Target
+198.94%
Consensus